According to Zhitong Finance App News, Wantai Biotech (603392.SH) disclosed its 2026 semi-annual report. During the reporting period, the company achieved operating income of 1,048 billion yuan, an increase of 24.29%; net profit loss attributable to shareholders of listed companies was 128 million yuan, a year-on-year narrowing; loss after deducting non-net profit of 169 million yuan, a year-on-year narrowing; and basic earnings per share were -0.10 yuan.

Zhitongcaijing · 1d ago
According to Zhitong Finance App News, Wantai Biotech (603392.SH) disclosed its 2026 semi-annual report. During the reporting period, the company achieved operating income of 1,048 billion yuan, an increase of 24.29%; net profit loss attributable to shareholders of listed companies was 128 million yuan, a year-on-year narrowing; loss after deducting non-net profit of 169 million yuan, a year-on-year narrowing; and basic earnings per share were -0.10 yuan.